An Iron-Catalyzed Bond-Making/Bond-Breaking Cascade Merges Cycloisomerization and Cross-Coupling Chemistry by Echeverria, P. & Fürstner, A.
Supporting Information
An Iron-Catalyzed Bond-Making/Bond-Breaking Cascade Merges
Cycloisomerization and Cross-Coupling Chemistry
Pierre-Georges Echeverria and Alois Frstner*
anie_201604531_sm_miscellaneous_information.pdf
S-2 
Table S-1. Optimization of the Reaction Conditions 




t (min) Conversion 
(%, NMR) 
Yield E:Z 
1 Fe(acac)3 20 --- 20 100 86% 97:3 
2 Fe(acac)3 20 tmeda (20) 10 96 91% 97:3 
3 Fe(acac)3 20 dppe (20) 80 100 82% 97:3 
4 Fe(acac)3 10 --- 50 100 91% 97:3 
5 Fe(acac)3 5 --- 60 93 84% 98:2 
6 Fe(acac)3 5 --- 120 100 90% 98:2 
7 Fe(acac)3 1 --- 1140 93 55% 98:2 
8 FeBr2 20 --- 600 100 nd 98:2 
9 20 --- 120 100 nd 95:5 
Control Experiments 
A series of control experiments proved that simple arylalkynes do not undergo carbometalation under 
the chosen conditions even if the mixture is allowed to reach room temperature. The examples shown in 
Scheme S-1 are representative. 
Scheme S-1. Representative control experiments that provide additional evidence that the observed 
reaction cascade is not trigged by an ordinary iron catalyzed carbometalation of the alkyne unit. 
S-3 
 
Even if the flanking alkene in substrates of type 1 provides assistance,1 a triggering carbometalation of 1d 
would almost certainly afford the opposite regiochemical pattern to what is experimentally observed 
due to the directing effect of the silyl group.2 Furthermore, it is unlikely that the tethering O-atom in 
substrates of type 1 exerts a critical role by coordination to the catalyst and/or Grignard reagent, 
because the MOM-derivative analogous to substrate 1a also failed to undergo carbometalation under 
otherwise identical conditions. 
 
Supplementary Crystallographic Information 
 




Figure S-2. Structure of one of the two independent molecules of compound 3c in the unit cell. 
                                                          
1
  For evidence that alkenes can facilitate iron catalyzed processes without taking part in the net reaction, see: S. 
Gülak, A. Jacobi von Wangelin, Angew. Chem. Int. Ed. 2012, 51, 1357-1361; 
2
  For the regiochemical course of a carbometalation of trimethyl(phenylethynyl)silane, see: M. Yamaguchi, T. 
Sotokawa, M. Hirama, Chem. Commun. 1997, 743-744. 
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X-ray Crystal Structure Analysis of Compound 3c: C16 H18 O3, Mr = 258.30  g · mol
-1, colorless plate, crystal 
size 0.58 x 0.52 x 0.52 mm, triclinic, space group P1¯, a =  7.7944(3) Å, b = 10.4981(4) Å, c = 18.9565(7) Å, 
 = 101.4730(10)°,  = 94.4570(10)°,  = 111.5750(10)°, V = 1394.14(9) Å3, T = 200 K, Z = 4, Dcalc = 1.231 
g·cm3,  = 1.54178 Å, (Cu-K) = 0.678 mm-1, Empirical absorption correction (Tmin = 0.66, Tmax = 0.78), 
Bruker AXS X8 Proteum diffractometer,  2.411 <  < 67.493°, 32194 measured reflections, 4816 
independent reflections, 4688 reflections with I > 2(I), Structure solved by direct methods and refined 
by full-matrix least-squares against F2 to R1 = 0.036 [I > 2(I)], wR2 =  0.092, 349 parameters, H atoms 




General. All reactions were carried out under Ar in glassware dried with a heat gun under vacuum 
(Schlenk line). The solvents were purified by distillation over the indicated drying agents and were 
transferred under Ar: THF, Et2O (Mg/anthracene), CH2Cl2, toluene (Na/K), MeOH (Mg, stored over MS 3Å); 
DMF, CH3CN , NEt3 and pyridine were dried by an adsorption solvent purification system based on 
molecular sieves. Thin layer chromatography (TLC): Macherey-Nagel precoated plates (POLYGRAM® 
SIL/UV254); Flash chromatography: Merck silica gel 60 (40–63 μm or 15–40 μm (fine)) with predistilled or 
HPLC grade solvents. NMR: Spectra were recorded on Bruker DPX 300, AV 400 or AV 500 spectrometers in 
CDCl3; chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals 
were used as references and the chemical shifts converted to the TMS scale (CDCl3: δC =77.0 ppm; 
residual CHCl3 in CDCl3: δH =7.26 ppm). IR: Spectrum One (Perkin-Elmer) spectrometer, wavenumbers () 
in cm1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ3000 (Bruker), accurate mass determinations: 
Bruker APEX III FT-MS (7 T magnet) or Mat 95 (Finnigan). Unless stated otherwise, all commercially 
available compounds (Alfa Aesar, Sigma-Aldrich) were used as received. Fe(acac)3 (> 99.9%) was 
purchased from Sigma-Aldrich. The Grignard reagents were commercially available compounds (Alfa 
Aesar, Sigma-Aldrich); they were titrated prior to use according to a literature procedure.3 
Preparation of the Substrates 
 
Compound S2. 1-Propynylmagnesium bromide (0.5 M in THF, 15.1 mmol, 30.3 mL) was added dropwise to 
a solution of dried ZnBr2 (prepared according to ref. 4, 15.1 mmol, 3.4 g) in THF (90 mL) at room 
temperature, resulting in the immediate formation of a white precipitate. The suspension was stirred for 
15 min before it was filtrated under argon. The filtrate was added to a solution of S1 (7.6 mmol, 2 g)5 and 
Pd(PPh3)4 (0.8 mmol, 963 mg. 11 mol%) in THF (20 mL) and the resulting mixture was stirred for 1.5 h at 
75°C. After reaching room temperature, the mixture was filtered through a pad of silica, rinsing with tert-
butyl methyl ether. The combined filtrates were evaporated and the residue was purified by flash 
chromatography (hexane/EtOAc, 20/1) to give the title compound as a pale yellow oil (1.14 g, 85%).6 1H 
NMR (300 MHz, CDCl3) δ 7.38 (dd, J = 7.6, 1.8 Hz, 1H), 7.26 – 7.18 (m, 1H), 7.09 (dd, J = 8.3, 1.2 Hz, 1H), 
6.94 (td, J = 7.5, 1.2 Hz, 1H), 5.24 (s, 2H), 3.53 (s, 3H), 2.10 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 157.7, 133.6, 
128.8, 121.8, 115.4, 114.6, 95.1, 89.8, 75.8, 56.1, 4.7; IR (neat) 3072, 3029, 2996, 2956, 2915, 2848, 2826, 
1596, 1574, 1489, 1440, 1404, 1378, 1310, 1261, 1229, 1196, 1151, 1112, 1078, 1044, 989, 966, 920, 793, 
751, 686, 644, 568, 542, 481, 443 cm-1; MS (EI) m/z (%): 45 (100), 51 (7), 63 (5), 77 (15), 91 (7), 103 (8), 115 
(19), 31 (49), 145 (52), 161 (13), 176 (28); HRMS (APPIpos): calcd for C11H12O2: 176.08318; found: 
176.08326. 
Compound S3. The MOM ether S2 (8.0 mmol, 1.4 g) was dissolved in MeOH (16 mL) and HCl (36% w/w, 
19.0 mmol, 1.6 mL) was added dropwise. The resulting yellow solution was stirred for 6 h at 
room temperature, the acid was neutralized with saturated NaHCO3, the aqueous layer was 
extracted with EtOAc and the combined organic phases were dried over Na2SO4. Evaporation 
of the solvent followed by purification of the residue by flash chromatography (hexane/Et2O 
                                                          
3
  Krasovskiy, A.; Knochel, P. Synthesis 2006, 890. 
4
  Jensen, A. E,; Kneisel, F.; Knochel, P. Org. Synth. 2002, 79, 35. 
5
  Liu, J.; Liu, Y. Org. Lett. 2012, 14, 4742. 
6
  Compound 1b was synthesized using a modified Negishi procedure: Hoffmeister, L.; Persich, P.; Fürstner, A. 
Chem. Eur. J. 2014, 20, 1396. 
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20:1) gave the title compound as a volatile yellow oil (936 mg, 89%). 1H NMR (400 MHz, CDCl3) δ 7.30 (dd, 
J = 7.7, 1.7 Hz, 1H), 7.23 – 7.19 (m, 1H), 6.94 (dd, J = 8.2, 0.9 Hz, 2H), 6.85 (td, J = 7.4, 1.1 Hz, 1H), 5.86 (s, 
1H), 2.13 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 156.5, 131.4, 129.6, 120.1, 114.3, 110.1, 93.3, 73.8, 4.5. The 
data are in agreement with those previously reported in the literature.7  
 
Compound 1a. DABCO (0.8 mmol, 84 mg, 11 mol%) was added in one portion to a mixture of phenol S3 
(6.8 mmol, 894 mg) and methyl propiolate (6.8 mmol, 0.6 mL) in CH2Cl2 (40 mL) at 0 °C. The mixture was 
stirred at ambient temperature for 1 h before the solvent was removed in vacuo. The brown residue (E:Z = 
95:5, NMR) was purified by flash chromatography (hexane/EtOAc, 20:1) to afford a pure fraction of E-1a 
(yellow oil, 956 mg, 65%) and a second fraction containing a mixture of E-1a and the trans enyne S4 
resulting from the homo-coupling of the alkyne.8 1H NMR (300 MHz, CDCl3) δ 7.77 (d, J = 12.3 Hz, 1H), 7.42 
(dd, J = 7.7, 1.7 Hz, 1H), 7.27 (td, J = 7.7, 1.7 Hz, 1H), 7.12 (td, J = 7.6, 1.2 Hz, 1H), 7.03 (dd, J = 8.1, 1.2 Hz, 
1H), 5.49 (d, J = 12.3 Hz, 1H), 3.72 (s, 3H), 2.06 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 167.6, 160.0, 155.9, 
133.8, 129.0, 125.1, 118.8, 116.2, 101.3, 92.0, 74.2, 51.2, 4.5; IR (neat) 3078, 2995, 2951, 2917, 2847, 
2241, 1711, 1646, 1629, 1600, 1570, 1487, 1436, 1320, 1291, 1255, 1193, 1117, 1098, 1043, 936, 830, 
804, 754, 681, 615, 604, 568, 515, 471 cm-1; MS (EI) m/z (%): 39 (7), 51 (13), 64 (18), 77 (20), 89 (15), 102 
(10), 115 (28), 128 (70), 145 (14), 157 (34), 173 (16), 185 (100), 201 (17), 216 (34); HRMS (APPIpos): calcd 
for C13H12O3: 216.07810; found: 216.07823. 
 
Compounds 1b and 1c are known compounds and were 
prepared according to a literature procedure.5  
 
 
Compound 1d.9 Prepared analogously as a pale orange oil (188 mg, 87%). 1H NMR (400 MHz, CDCl3) δ 7.78 
(d, J = 12.2 Hz, 1H), 7.49 (d, J = 7.7 Hz, 1H), 7.33 (t, J = 7.8 Hz, 1H), 7.15 (t, J = 7.6 Hz, 
1H), 7.05 (d, J = 8.2 Hz, 1H), 5.52 (d, J = 12.3 Hz, 1H), 3.72 (s, 3H), 0.23 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 167.6, 159.9, 156.4, 134.0, 130.0, 125.1, 118.9, 115.3, 101.3, 101.1, 
99.1, 51.3, 0.3 (3C); IR (neat) 3079, 2955, 2900, 2845, 2162, 1715, 1646, 1632, 1599, 
1571, 1483, 1444, 1320, 1285, 1235, 1190, 1165, 1116, 1046, 945, 864, 836, 788, 755, 
719, 701, 642, 616, 577, 539, 516, 471, 429 cm-1; MS (EI) m/z (%): 43 (6), 53 (5), 59 (24), 73 (12), 89 (100), 
107 (13), 115 (24), 129 (7), 143 (7), 159 (13), 175 (6), 185 (17), 201 (25), 211 (10), 231 (8), 244 (13), 259 
(78); HRMS (ESIpos): calcd for C15H18O3SiNa: 297.09174; found: 297.09171. 
  
                                                          
7
  Yoneda, E.; Sugioka, T.; Hirao, K.; Zhang, S.-W.; Takahashi, S. J. Chem. Soc., Perkin Trans. 1 1998, 477. 
8
  For the addition of phenol to methyl propiolate, see ref 1 and the following: Fan, M.-J., Li, G.-Q.; Li, L.-H.; Yang, 
S.-D.; Liang, Y.-M. Synthesis 2006, 2286. 
9
  Kimura, M.; Ezoe, A.; Mori, M.; Tamaru, Y. J. Am. Chem. Soc. 2005, 127, 201. 
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Compound 1f.10 Prepared analogously as a white solid, 308 mg, 81%). m.p. = 75 – 77 °C. 1H NMR (400 
MHz, CDCl3) δ 8.15 (d, J = 13.8 Hz, 1H), 7.56 – 7.51 (m, 1H), 7.43 – 7.39 (m, 2H), 7.35 – 
7.32 (m, 1H), 4.63 (d, J = 13.8 Hz, 1H), 3.68 (s, 3H), 3.14 (s, 3H), 2.37 (t, J = 7.0 Hz, 2H), 
1.55 – 1.48 (m, 2H), 1.45 – 1.36 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 167.4, 142.4, 135.5, 134.0, 131.2, 130.0, 129.4, 124.0, 99.3, 97.2, 76.8, 51.3, 
41.2, 30.4, 21.9, 19.1, 13.5; IR (neat) 3023, 2956, 2933, 2873, 2232, 1711, 1625, 1597, 1567, 1487, 1436, 
1360, 1321, 1290, 1254, 1234, 1191, 1165, 1128, 1095, 1041, 958, 900, 871, 855, 832, 789, 753, 699, 666, 
607, 597, 552, 528, 516, 481, 411 cm-1; MS (EI) m/z (%): 41 (4), 59 (11), 77 (7), 91 (3), 127 (18), 142 (9), 154 
(66), 167 (42), 182 (95), 196 (73), 214 (43), 224 (40), 256 (100), 276 (26), 304 (17); HRMS (ESIpos): calcd 




Compound 1e. DABCO (0.18 mmol, 19.9 mg, 10 mol%) was added in one portion to a mixture of phenol S5 
(1.77 mmol, 309 mg)5 and ethynyl p-tolyl sulfone (1.77 mmol, 319.6 mg) in CH2Cl2 (10 mL) at 0 °C. The 
mixture was stirred for 1 h at ambient temperature and the solvent was evaporated. The brown residue 
(Z:E = 75:25, NMR) was purified by flash chromatography (hexane/EtOAc, 9:1 then 8:2) to afford E-1e 
(pale yellow oil, 177 mg, 28%) and a second fraction containing the Z-1e (pale yellow oil, 451 mg, 72%). 
Spectral data of E-1e: 1H NMR (400 MHz, CDCl3) δ 7.79 – 7.76 (m, 3H), 7.42 (dd, J = 7.7, 1.6 Hz, 1H), 7.31 
(d, J = 8.2 Hz, 2H), 7.27 (dd, J = 7.5, 1.6 Hz, 1H), 7.15 (td, J = 7.6, 1.0 Hz, 1H), 7.03 (dd, J = 8.2, 0.8 Hz, 1H), 
5.90 (d, J = 11.9 Hz, 1H), 2.43 (s, 3H), 2.34 (t, J = 7.0 Hz, 2H), 1.56 – 1.49 (m, 2H), 1.47 – 1.38 (m, 2H), 0.91 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 158.5, 155.3, 143.8, 139.2, 133.8, 129.7 (2C), 129.1, 127.1 
(2C), 125.8, 119.3, 116.4, 111.3, 97.2, 74.7, 30.5, 21.9, 21.6, 19.2, 13.6; IR (neat) 3065, 2957, 2931, 2872, 
2233, 1631, 1615, 1598, 1569, 1485, 1445, 1313, 1302, 1259, 1219, 1200, 1137, 1102, 1082, 1036, 1018, 
944, 888, 863, 802, 760, 705, 662, 619, 606, 579, 559, 537 cm-1. 
Spectral data of Z-1e: 1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 2H), 7.39 (dd, J = 7.6, 1.7 Hz, 1H), 7.30 
(d, J = 8.0 Hz, 2H), 7.23 (td, J = 7.8, 1.8 Hz, 1H), 7.12 (td, J = 7.6, 1.2 Hz, 1H), 6.95 (dd, J = 8.1, 1.3 Hz, 1H), 
6.81 (d, J = 6.4 Hz, 1H), 5.78 (d, J = 6.5 Hz, 1H), 2.42 (s, 3H), 2.27 (t, J = 7.0 Hz, 2H), 1.52 – 1.44 (m, 2H), 
1.43 – 1.35 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 156.6, 152.8, 143.8, 139.7, 133.8, 
129.3 (2C), 128.9, 127.7 (2C), 125.5, 118.9, 115.8, 110.6, 97.3, 74.6, 30.4, 22.0, 21.6, 19.2, 13.6; IR (neat) 
3076, 3028, 2957, 2931, 2871, 1627, 1597, 1569, 1486, 1444, 1402, 1380, 1316, 1302, 1291, 1259, 1240, 
1202, 1183, 1141, 1115, 1083, 1067, 1040, 1019, 944, 884, 814, 754, 708, 665, 644, 580, 552, 525, 514, 
466 cm-1; HRMS (ESIpos): calcd for C21H22O3SNa: 377.11819; found: 377.11870. 
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Compound 4.11 Methyl propiolate (2.19 mmol, 0.20 mL) was added dropwise to a stirred solution of 
alcohol S6 (2.19 mmol, 320 mg)12 and freshly distilled tributylphosphine (0.4 mmol, 0.1 mL, 18 mol%) in 
CH2Cl2 (10 mL) at room temperature, resulting in a color change to dark brown. The mixture was stirred 
for 16 h before the solvent was removed under vacuum. The residue was purified by flash 
chromatography on silica (hexane/EtOAc, 9:1) to afford the title compound as a colorless solid (453 mg, 
90%); m.p. = 44 – 46 °C. 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 12.7 Hz, 1H), 7.38 – 7.35 (m, 2H), 7.27 – 
7.22 (m, 3H), 5.23 (d, J = 12.6 Hz, 1H), 3.99 (t, J = 6.8 Hz, 2H), 3.66 (s, 3H), 2.79 (t, J = 6.8 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) δ 168.0, 162.1, 131.6 (2C), 128.2 (2C), 128.0, 123.0, 96.7, 84.7, 82.4, 69.0, 51.1, 20.2; IR 
(neat) 2949, 1705, 1641, 1623, 1572, 1490, 1464, 1436, 1389, 1332, 1287, 1238, 1207, 1189, 1127, 1047, 
988, 968, 952, 917, 823, 755, 691, 602, 576, 561, 527, 502, 456, 420 cm-1; MS (EI) m/z (%): 51 (7), 63 (6), 
77 (13), 91 (15), 102 (11), 115 (30), 128 (100), 141 (8), 159 (3), 171 (18), 187 (1), 199 (7), 215 (1), 229 (21); 
HRMS (ESIpos): calcd for C14H14O3Na: 253.08351; found: 253.08351. 
 
 
Compound 7.13 A solution of NaHMDS (2.98 mmol, 547 mg) in THF (10 mL) was added dropwise at –78 °C 
to a solution of S7 (2.74 mmol, 543 mg) 14 in THF (10 mL). The mixture was stirred for 30 min at 78 °C 
before (Z)-iodo acrylate (3.01 mmol, 0.39 mL) was added dropwise. The resulting yellow solution was 
warmed to –40 °C and stirring was continued for 10 h at this temperature. The reaction was quenched 
with saturated aqueous NH4Cl at –40 °C and the resulting mixture allowed to reach room temperature 
before it was diluted with water and EtOAc. The aqueous phase was extracted with EtOAc and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude material (E:Z = 
68:32, NMR) was purified by flash chromatography (hexane/EtOAc, 9:1) to afford the title compound as a 
separable mixture of the two isomers (colorless oil, 710 mg, 88% combined yield). Spectral data of E-7: 1H 
NMR (400 MHz, CDCl3) δ 7.33 (d, J = 16.4 Hz, 1H), 5.92 (d, J = 16.4 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.76 (s, 
6H), 2.33 – 2.29 (m, 2H), 2.12 – 2.07 (m, 2H), 1.75 (t, J = 2.5 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 169.3 (2C), 165.6, 142.8, 123.4, 77.3, 76.8, 60.8, 59.0, 53.1 (2C), 34.7, 14.4, 14.2, 3.4; IR 
(neat) 2981, 2956, 2921, 2849, 1735, 1651, 1436, 1392, 1368, 1252, 1226, 1192, 1085, 1071, 1034, 981, 
                                                          
11
  (a) Inanaga, J.; Baba, Y.; Hanamoto, T. Chem. Lett. 1993, 22, 241. (b) O’Rourke, N. F.; Davies, K. A.; Wulff, J. E. J. 
Org. Chem. 2012, 77, 8634. 
12
  Panteleev, J.; Huang, R. Y.; Lui, E. K. J.; Lautens, M. Org. Lett. 2011, 13, 5314. 
13
  Prepared by using a modified procedure: Esteban, J.; Costa, A. M.; Gómez, À.; Vilarrasa, J. Org. Lett. 2008, 10, 
65. 
14
  Hog, D. T.; Huber, F. M. E.; Jiménez-Osés, G.; Mayer, P.; Houk, K. N.; Trauner, D. Chem. Eur. J. 2015, 21, 13646.  
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939, 915, 864, 830, 793, 709, 594, 537, 488, 427 cm-1; MS (ESIpos) m/z = 297 ([M+H]), 314 ([M+NH4]), 319 
([M+Na]), 615 ([2M+Na]); HRMS (ESIpos): calcd for C15H20O6Na: 319.11521; found: 319.11526. 
Spectral data of Z-7: 1H NMR (400 MHz, CDCl3) δ 6.87 (d, J = 12.3 Hz, 1H), 6.00 (d, J = 12.2 Hz, 1H), 4.13 (q, 
J = 7.2 Hz, 2H), 3.72 (s, 6H), 2.51 – 2.47 (m, 2H), 2.13 – 2.07 (m, 2H), 1.73 (t, J = 2.5 Hz, 3H), 1.26 (t, J = 7.1 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.6 (2C), 165.2, 143.4, 121.8, 77.7, 76.5, 60.5, 58.8, 53.0 (2C), 34.7, 
14.9, 14.1, 3.4. 
 
 
Compound S8. A solution of malonate S7 (1.51 mmol, 300 mg) in DMF (1 mL) was added dropwise to a 
suspension of NaH (1.75 mmol, 42 mg) in DMF (1 mL) at 0 °C. The resulting mixture was stirred at room 
temperature for 15 min. The solution was cooled to 0 °C before 1,2-dibromoethane (1.62 mmol, 0.14 mL) 
was added. The mixture was stirred at ambient temperature for 15 h before the reaction was carefully 
quenched with saturated aqueous NH4Cl. The aqueous phase was extracted with methyl tert-butyl ether 
and the combined organic extracts were washed with brine, dried over Na2SO4, filtered, and concentrated. 
The crude material was purified by flash chromatography (hexanes/EtOAc, 20:1) to afford the title 
compound as a colorless oil (247 mg, 53% yield). 1H NMR (400 MHz, CDCl3) δ 3.73 (s, 6H), 3.32 (app. t, J = 
8.0 Hz, 2H), 2.50 (app. t, J = 8.6 Hz, 2H), 2.12 (app. s, 4H), 1.76 (app. s, 3H); 13C NMR (100 MHz, CDCl3) δ 
170.7 (2C), 77.2, 76.6, 57.2, 52.7 (2C), 36.1, 32.2, 26.9, 14.2, 3.5; IR (neat) 2954, 2920, 2858, 2845, 1732, 
1435, 1348, 1260, 1217, 1200, 1180, 1088, 1064, 1038, 1012, 968, 887, 796, 740, 662, 576, 554, 519, 450, 
418 cm-1; MS (ESIpos) m/z = 305 ([M+H]), 322 ([M+NH4]), 327 ([M+Na]), 631 ([2M+Na]); HRMS (ESIpos): 
calcd for C12H17O4BrNa: 327.02025; found: 327.02026. 
Compound 10. A mixture of bromide S8 (0.73 mmol, 221 mg) and DBU (3.65 mmol, 0.55 mL) was stirred 
at 80 °C for 1.5 h. The mixture was cooled to room temperature, the reaction was quenched with 
saturated aqueous NH4Cl and the aqueous phase extracted with methyl tert-butyl ether. The combined 
extracts were washed with brine, dried over Na2SO4, filtered, and concentrated. The crude material was 
purified by flash chromatography (hexanes/EtOAc, 15:1) to afford the title compound as a colorless oil (47 
mg, 29%). 1H NMR (400 MHz, CDCl3) δ 6.30 (dd, J = 17.9, 10.9 Hz, 1H), 5.32 (d, J = 10.9 Hz, 1H), 5.18 (d, J = 
17.8 Hz, 1H), 3.73 (s, 6H), 2.30 – 2.26 (m, 2H), 2.12 – 2.06 (m, 2H), 1.75 (t, J = 2.5 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 170.4 (2C), 133.9, 117.3, 77.8, 76.2, 59.3, 52.7 (2C), 34.2, 14.2, 3.5; IR (neat) 2954, 2921, 
2854, 1733, 1635, 1435, 1281, 1258, 1225, 1197, 1084, 994, 932, 812, 785, 704, 654, 420 cm-1; MS (EI) m/z 
(%): 39 (12), 53 (36), 68 (25), 79 (21), 91 (24), 98 (49), 105 (67), 126 (93), 133 (28), 149 (6), 158 (100), 165 





Compound S10. 1-Hexyne (7.41 mmol, 0.85 mL), PdCl2(PPh3)2 (0.17 mmol, 117.1 mg) and CuI (0.43 mmol, 
81.8 mg) were successively added to a solution of S9 (6.74 mmol, 1.86 g)15 in freshly distilled NEt3 (67 mL). 
The resulting yellow solution was stirred at 50 °C for 17 h. After reaching room temperature, EtOAc was 
added and the suspension was filtered through a pad of Celite. Evaporation of the filtrate gave a brown 
residue which was purified by flash chromatography (hexane/EtOAc, 40:1) to afford the title compound as 
a yellow oil (1.43 g, 92%). 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 6.8 Hz, 1H), 7.29 – 7.22 (m, 3H), 3.86 (s, 
2H), 3.74 (s, 3H), 2.48 (t, J = 7.0 Hz, 2H), 1.67 – 1.60 (m, 2H), 1.57 – 1.48 (m, 2H), 1.00 (t, J = 7.3 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 171.7, 135.9, 132.0, 129.5, 127.6, 126.9, 124.3, 95.1, 78.5, 51.9, 39.7, 30.7, 21.9, 
19.1, 13.6; IR (neat) 3066, 3025, 2955, 2932, 2872, 1737, 1601, 1487, 1450, 1434, 1412, 1379, 1339, 1245, 
1207, 1157, 1103, 1043, 1011, 949, 926, 897, 867, 824, 755, 687, 632, 581, 547, 513, 464 cm-1; MS (EI) m/z 
(%): 91 (7), 102 (7), 115 (39), 129 (100), 141 (40), 155 (33), 171 (17), 188 (29), 201 (9), 215 (5), 230 (22); 
HRMS (APPIpos): calcd for C15H18O2: 230.13013; found: 230.13029. 
Compound 15. A solution of NaHMDS (0.47 mmol, 86.6 mg) in THF (2 mL) was added dropwise at 78 °C 
to a solution of S10 (0.43 mmol, 100 mg) in THF (2 mL). The yellow mixture was stirred for 15 min at –78 
°C before ethyl (Z)-iodo-acrylate (0.48 mmol, 61 µL) was slowly introduced and stirring was continued for 
3 h at –78 °C. The reaction was quenched with saturated aqueous NH4Cl at –78 °C and the mixture was 
allowed to reach room temperature before it was diluted with water and EtOAc. The aqueous phase was 
extracted with EtOAc and the combined organic layers were dried over Na2SO4, filtered, and concentrated. 
The residue was purified by flash chromatography (hexane/EtOAc, 20:1) to afford compound 15 as a 
slightly colored oil (86 mg, 60%) and second fraction containing isomer S11 as a colorless oil (18 mg, 13% 
yield). Spectral data of compound 15: 1H NMR (400 MHz, CDCl3) δ 7.40 (dd, J = 7.4, 1.7 Hz, 1H), 7.36 (dd, J 
= 7.6, 1.5 Hz, 1H), 7.25 (td, J = 7.4, 1.6 Hz, 1H), 7.20 (td, J = 7.5, 1.5 Hz, 1H), 6.65 (dd, J = 11.3, 9.4 Hz, 1H), 
6.06 (dd, J = 9.4, 1.1 Hz, 1H), 5.94 (dd, J = 11.3, 1.1 Hz, 1H), 4.18 (qd, J = 7.1, 5.2 Hz, 2H), 3.70 (s, 3H), 2.41 
(t, J = 7.1 Hz, 2H), 1.63 – 1.55 (m, 2H), 1.51 – 1.41 (m, 2H), 1.28 (t, J = 7.2 Hz, 3H), 0.94 (t, J = 7.3 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 172.2, 165.7, 144.3, 139.8, 132.7, 128.7, 128.1, 127.3, 123.6, 121.3, 95.7, 
78.3, 60.2, 52.3, 48.6, 30.6, 22.1, 19.2, 14.2, 13.6; IR (neat) 2956, 2934, 2873, 1736, 1717, 1648, 1485, 
1463, 1446, 1434, 1411, 1386, 1321, 1283, 1184, 1097, 1074, 1029, 926, 854, 824, 758 cm-1; MS (EI) m/z 
(%): 29 (11), 41 (8), 59 (5), 76 (9), 128 (13), 141 (29), 153 (43), 165 (45), 181 (32), 199 (65), 207 (29), 223 
(100), 239 (12), 250 (43), 285 (45), 296 (10), 328 (56); HRMS (ESIpos): calcd for C20H24O4Na: 351.15668; 
found: 351.15661. 
Spectral data of isomer S11: 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.43 (m, 1H), 7.30 – 7.24 (m, 3H), 7.14 – 
7.12 (m, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.73 (s, 3H), 3.08 (d, J = 7.4 Hz, 2H), 2.34 (t, J = 6.9 Hz, 2H), 1.55 – 
1.47 (m, 2H), 1.46 – 1.37 (m, 2H), 1.26 (t, J = 7.2 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 170.3, 166.8, 136.9, 136.2, 135.6, 132.0, 129.5, 127.8, 127.4, 124.1, 94.5, 78.7, 61.0, 52.1, 35.0, 30.7, 
21.9, 19.1, 14.1, 13.6; IR (neat) 2959, 2933, 2873, 1737, 1722, 1435, 1372, 1326, 1251, 1179, 1046, 1028, 
760, 734 cm-1; MS (EI) m/z (%): 29 (16), 57 (11), 85 (14), 115 (20), 128 (19), 141 (30), 153 (70), 165 (100), 
181 (45), 211 (53), 223 (27), 239 (61), 254 (25), 268 (73), 296 (14), 328 (46); HRMS (ESIpos): calcd for 
C20H24O4Na: 351.15668; found: 351.15658. 
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Compound 18.16 A vacuum-dried Schlenk tube containing Pd(PPh3)4 (32 µmol, 37.51 mg), CuI (40 µmol, 
7.62 mg) and CsF (3.43 mmol, 521 mg) was purged with argon before freshly distilled CH3CN (3 mL), 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate (1 mmol, 0.24 mL), allyl acetate (1.31 mmol, 0.14 mL) 
and 1-hexyne (1.11 mmol, 0.13 mL) were successively added. The resulting mixture was stirred at 50 °C for 
4 h. For work-up, the mixture was filtered through a pad of Celite which was carefully rinsed with CH2Cl2. 
The combined filtrates were evaporated and the residue was purified by flash chromatography on silica 
(hexane) to afford the title compound as a colorless liquid (136 mg, 68%). 1H NMR (300 MHz, CDCl3) δ 7.39 
(d, J = 7.3 Hz, 1H), 7.24 – 7.11 (m, 3H), 6.00 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H), 5.13 – 5.04 (m, 2H), 3.56 (d, J = 
6.7 Hz, 2H), 2.46 (t, J = 6.9 Hz, 2H), 1.67 – 1.55 (m, 2H), 1.54 – 1.45 (m, 2H), 0.96 (t, J = 7.2 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 141.8, 136.8, 132.2, 128.6, 127.7, 125.9, 123.6, 115.7, 94.4, 79.1, 38.7, 30.9, 22.0, 
19.2, 13.6. The data are in agreement with those previously reported in the literature.17 
 
Products 
General Procedure for Iron Catalyzed Reaction Cascade. Fe(acac)3 (5-20 mol%) was added to a Schlenk 
tube containing a solution of the 1,6-enyne in THF (0.01 M) and the orange mixture was cooled to –30 °C. 
A solution of the Grignard reagent in THF or Et2O (2 equiv) was added dropwise, resulting in an immediate 
color change to dark brown or dark green. Stirring was continued at –30 °C until TLC indicated complete 
consumption of the starting material. The reaction was then quenched with EtOH (1 mL). The mixture was 
concentrated, the residue suspended in CH2Cl2 and the mixture filtered through a pad of silica, eluting 
with hexane/EtOAc (1:1). The combined filtrates were evaporated and the residue was purified by flash 
chromatography to afford the desired product. 
Compound 3a. Pale yellow oil (90% yield, E/Z  98:2, NMR). 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 15.3 
Hz, 1H), 7.24 – 7.20 (m, 1H), 6.94 – 6.87 (m, 3H), 5.33 (d, J = 15.3 Hz, 1H), 4.85 (s, 1H), 
3.69 (s, 3H), 3.09 – 3.02 (m, 1H), 1.83 – 1.73 (m, 3H), 1.64 – 1.62 (m, 2H), 1.59 (s, 3H), 
1.49 – 1.38 (m, 4H), 1.25 – 1.17 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 168.2, 156.5, 
152.4, 140.7, 130.4, 129.1, 127.0, 125.0, 120.7 (2C), 119.3, 115.3, 51.5, 41.4, 31.5, 31.1, 
26.1, 25.9, 17.1; IR (neat) 3410, 2927, 2852, 1688, 1602, 1501, 1486, 1446, 1435, 1374, 
1351, 1286, 1233, 1192, 1114, 1083, 1020, 972, 930, 909, 888, 863, 843, 828, 752, 730, 705, 621, 602, 550, 
511, 491, 449, 412 cm-1; MS (ESIpos) m/z = 301 ([M+H]), 323 ([M+Na]), 623 ([2M+Na]), 923 ([3M+Na]); 
HRMS (ESIpos): calcd for C19H24O3Na: 323.16176; found: 323.16175. 
 
Compound 3b. White solid (93% yield). m.p. = 149 – 151 °C. 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 15.3 
Hz, 1H), 7.25 – 7.20 (m, 1H), 6.95 – 6.88 (m, 3H), 5.32 (d, J = 15.3 Hz, 1H), 5.04 (s, 1H), 
3.69 (s, 3H), 2.14 (s, 3H), 1.69 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 168.1, 152.6, 147.4, 
141.9, 130.5, 129.2, 128.3, 124.5, 120.7, 118.9, 115.4, 51.5, 23.6, 20.6; IR (neat) 3412, 
2996, 2951, 1697, 1614, 1578, 1483, 1454, 1437, 1371, 1331, 1311, 1292, 1243, 1215, 
1193, 1173, 1149, 1126, 1049, 1028, 1013, 971, 930, 876, 859, 823, 773, 763, 733, 682, 623, 606, 584, 542, 
517, 485, 455, 444 cm-1; MS (EI) m/z (%): 31 (7), 43 (15), 51 (13), 63 (12), 77 (32), 91 (29), 107 (12), 115 
(34), 131 (61), 145 (33), 159 (100), 173 (51), 185 (87), 200 (13), 217 (40), 232 (87); HRMS (ESIpos): calcd 
for C14H16O3Na: 255.09916; found: 255.09922. 
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Compound 3c. Colorless solid (90% yield, E/Z = 99:1, NMR). m.p. = 86 – 88 °C. 1H NMR (400 MHz, CDCl3) δ 
8.24 (d, J = 15.3 Hz, 1H), 7.26 – 7.20 (m, 1H), 6.95 – 6.88 (m, 3H), 5.35 (d, J = 15.3 Hz, 
1H), 5.00 (s, 1H), 3.69 (s, 3H), 2.28 (tt, J = 8.4, 5.2 Hz, 1H), 1.32 (s, 3H), 0.96 – 0.87 (m, 
2H), 0.82 – 0.77 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 168.2, 152.6, 151.4, 141.6, 130.4, 
129.2, 128.4, 125.1, 120.7, 118.8, 115.4, 51.5, 15.7, 14.4, 6.7 (2C); IR (neat) 3391, 
3085, 3009, 2949, 1688, 1600, 1580, 1486, 1447, 1435, 1289, 1249, 1231, 1192, 1167, 
1129, 1096, 1051, 1033, 973, 917, 860, 840, 813, 755, 732, 681, 631, 604, 586, 549, 528, 481, 455, 431 cm-
1; MS (EI) m/z (%): 29 (100), 36 (34), 55 (14), 65 (12), 77 (30), 91 (26), 107 (32), 115 (32), 131 (33), 141 (21), 
157 (32), 169 (50), 184 (68), 199 (37), 211 (12), 226 (6), 243 (10), 258 (43); HRMS (ESIpos): calcd for 
C16H19O3: 259.13287; found: 259.13281. 
Compound 3d. Colorless oil (94% yield, E/Z = 99:1, NMR). 1H NMR (400 MHz, CDCl3) δ 8.11 (d, J = 15.4 Hz, 
1H), 7.26 – 7.18 (m, 1H), 6.90 – 6.85 (m, 3H), 6.22 (s, 1H), 5.31 (d, J = 15.3 Hz, 1H), 4.69 
(t, J = 3.9 Hz, 1H), 4.13 – 4.03 (m, 2H), 3.74 – 3.65 (m, 2H), 3.69 (s, 3H), 3.16 (ddd, J = 
13.9, 9.5, 4.6 Hz, 1H), 2.20 (ddd, J = 11.4, 7.0, 4.3 Hz, 1H), 2.06 – 1.89 (m, 3H), 1.69 (s, 
3H), 1.27 (app. d, J = 13.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 168.1, 153.5, 150.3, 
142.8, 129.8, 129.0 (2C), 124.5, 120.0, 118.8, 115.3, 102.2, 67.1, 67.0, 51.3, 32.7, 28.2, 
25.2, 21.4; IR (neat) 3400, 2952, 2932, 2853, 1712, 1614, 1579, 1486, 1448, 1434, 1400, 1378, 1289, 1249, 
1216, 1193, 1167, 1134, 1114, 1093, 1074, 1050, 1031, 999, 976, 948, 927, 886, 864, 829, 798, 753, 683, 
666, 636, 604,508, 475, 437 cm-1; MS (ESIpos) m/z = 333 ([M+H]), 355 ([M+Na]), 687 ([2M+Na]); HRMS 
(ESIpos): calcd for C19H24O5Na: 355.15160; found: 355.15173. 
Compound 3e. Colorless oil (75% yield, E/Z = 96:4, NMR). 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 15.3 Hz, 
1H), 7.25 – 7.20 (m, 1H), 6.95 – 6.88 (m, 3H), 5.33 (d, J = 15.3 Hz, 1H), 4.85 (s, 1H), 3.69 
(s, 3H), 3.48 (hept, J = 6.8 Hz, 1H), 1.57 (s, 3H), 1.14 (dd, J = 6.8, 5.0 Hz, 6H); 13C NMR 
(100 MHz, CDCl3) δ 168.1, 156.8, 152.4, 140.6, 130.4, 129.1, 126.9, 125.0, 120.8, 119.4, 
115.4, 51.5, 30.2, 21.3, 21.0, 15.6; IR (neat) 3401, 2966, 2872, 1689, 1602, 1486, 1447, 
1435, 1362, 1285, 1193, 1167, 1129, 1098, 1052, 1032, 973, 910, 864, 839, 753, 731, 
682, 647, 636, 605, 591, 554, 533, 496, 459, 442, 405 cm-1; MS (EI) m/z (%): 43 (16), 55 (8), 65 (7), 77 (17), 
91 (14), 115 (23), 131 (30), 145 (20), 157 (31), 175 (25), 185 (100), 201 (5), 217 (49), 229 (4), 245 (13), 260 
(26); HRMS (ESIpos): calcd for C16H20O3Na: 283.13046; found: 283.13072. 
Compound 3f. In this case, the solution of the Grignard reagent was added over 30 min via syringe pump 
at 30°C; colorless oil (84% yield, E/Z = 97:3, NMR). 1H NMR (400 MHz, CDCl3) δ 7.96 
(d, J = 15.2 Hz, 1H), 7.25 – 7.20 (m, 1H), 6.95 – 6.88 (m, 3H), 5.33 (d, J = 15.2 Hz, 1H), 
4.88 (s, 1H), 3.69 (s, 3H), 2.58 – 2.43 (m, 2H), 1.67 (s, 3H), 1.59 – 1.51 (m, 2H), 1.40 – 
1.31 (m, 6H), 0.94 – 0.82 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 167.4, 151.8, 
151.4, 140.7, 129.7, 128.5, 127.5, 124.0, 120.0, 118.4, 114.7, 50.8, 33.5, 30.9, 28.5, 28.3, 21.9, 20.9, 13.4; 
IR (neat) 3460, 2953, 2929, 2857, 1736, 1649, 1608, 1577, 1463, 1378, 1308, 1260, 1243, 1202, 1168, 
1129, 1105, 1086, 1037, 1018, 987, 926, 901, 853, 752, 726, 676, 637, 619, 584, 558, 525, 464, 451 cm-1. 
Compound 3g. Pale yellow oil (90% yield, E:Z > 99:1, NMR). 1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 15.4 
Hz, 1H), 7.24 – 7.20 (m, 1H), 6.94 – 6.87 (m, 3H), 5.29 (d, J = 15.4 Hz, 1H), 4.98 (s, 
1H), 3.68 (s, 3H), 2.12 (s, 3H), 1.96 (t, J = 7.9 Hz, 2H), 1.41 – 1.21 (m, 2H), 1.13 (sext, J 
= 6.9 Hz, 2H), 0.75 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 168.1, 152.6, 151.8, 
142.1, 130.7, 129.1, 128.1, 124.3, 120.6, 119.1, 115.3, 51.5, 36.7, 29.9, 22.5, 18.3, 
13.7; IR (neat) 3399, 2955, 2929, 2871, 2860, 1713, 1692, 1608, 1486, 1448, 1436, 1377, 1309, 1284, 
1225, 1195, 1170, 1132, 1107, 1073, 1037, 975, 925, 864, 828, 754, 731, 694, 681, 633, 609, 583, 549, 521 
cm-1; MS (EI) m/z (%): 41 (4), 55 (4), 77 (6), 91 (7), 107 (12), 131 (21), 145 (16), 157 (17), 171 (45), 185 
(100), 199 (21), 217 (32), 231 (23), 243 (7), 259 (4), 274 (42); HRMS (ESIpos): calcd for C17H22O3Na: 
297.14611; found: 297.14600. 
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Compound 3h. Colorless oil (72% yield, E/Z > 99:1, NMR). 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 15.4 Hz, 
1H), 7.25 – 7.19 (m, 1H), 6.94 – 6.90 (m, 3H), 5.31 (d, J = 15.4 Hz, 1H), 4.86 (s, 1H), 
3.68 (s, 3H), 2.06 (tt, J = 8.5, 5.4 Hz, 1H), 1.69 – 1.58 (m, 2H), 1.32 – 1.17 (m, 2H), 1.08 
(sext, J = 7.2 Hz, 2H), 1.02 – 0.94 (m, 2H), 0.73 – 0.64 (m, 5H); 13C NMR (100 MHz, 
CDCl3) δ 168.1, 155.9, 152.5, 142.1, 130.7, 129.2, 129.2, 124.6, 120.6, 118.8, 115.3, 
51.4, 30.9, 30.5, 22.7, 13.5, 13.0, 7.3, 7.0; IR (neat) 3399, 3083, 3008, 2954, 2931, 
2871, 1689, 1604, 1578, 1485, 1447, 1435, 1282, 1230, 1192, 1166, 1132, 1105, 1073, 1032, 973, 917, 
862, 842, 817, 753, 731, 665, 648, 612, 590, 571, 527, 483, 458, 446, 425 cm-1; MS (ESIneg) m/z: 299 ([M-
H]), 599 ([2M-H]); HRMS (ESIneg): calcd for C19H23O3: 299.16527; found: 299.16531. 
Compound 3i. Colorless oil (93% yield, Z:E > 99:1, NMR). 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J = 15.4 Hz, 
1H), 7.24 – 7.20 (m, 1H), 6.92 – 6.87 (m, 3H), 5.39 (d, J = 15.4 Hz, 1H), 5.03 (s, 1H), 3.69 
(s, 3H), 2.16 (s, 3H), 0.18 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 168.0, 153.8, 153.2, 
140.8, 140.4, 131.2, 129.6, 126.5, 120.8, 120.3, 115.4, 51.6, 18.5, -1.2 (3C); IR (neat) 
3411, 3062, 3030, 2952, 2896, 1716, 1693, 1608, 1575, 1485, 1447, 1436, 1281, 1247, 
1193, 1169, 1135, 1096, 1075, 1036, 1019, 977, 920, 834, 753, 690, 655, 622, 591, 546, 502, 482, 431, 406 
cm-1; MS (EI) m/z (%): 45 (16), 59 (23), 73 (100), 89 (43), 115 (21), 128 (10), 141 (11), 157 (10), 171 (22), 
185 (11), 201 (32), 215 (36), 231 (20), 243 (41), 258 (77), 275 (11), 290 (32); HRMS (ESIpos): calcd for 
C16H22O3SiNa: 313.12304; found: 313.12324. 
Compound 3j and 4j. The product was isolated as a yellow oil (74% yield, E/Z = 99:1, NMR) together with a 
second fraction consisting of the Michael adduct 4j (yellow oil, 22% yield, Z/E (= 74:26.).  
Spectral data of 3j: 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 14.6 Hz, 1H), 7.69 (d, J = 8.3 Hz, 2H), 7.27 (d, J = 
8.0 Hz, 2H), 7.19 (ddd, J = 8.0, 6.5, 2.8 Hz, 1H), 6.89 – 6.86 (m, 3H), 5.73 (d, J = 14.9 
Hz, 1H), 2.40 (s, 3H), 2.05 (tt, J = 8.5, 5.4 Hz, 1H), 1.64 (t, J = 7.8 Hz, 2H), 1.29 – 
1.15 (m, 2H), 1.11 – 1.00 (m, 4H), 0.76 – 0.65 (m, 2H), 0.67 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 158.4, 152.4, 143.9, 139.5, 138.0, 130.7, 129.8 (2C), 
129.4, 127.9, 127.5, 127.4 (2C), 123.8, 120.7, 115.6, 30.8, 30.6, 22.7, 21.6, 13.5, 
13.2, 7.5, 7.2; MS (EI) m/z (%): 69 (52), 85 (41), 131 (42), 171 (38), 199 (96), 241 (100), 304 (8), 355 (18), 
396 (18); HRMS (ESIpos): calcd for C24H28O3SNa: 419.16522; found: 419.16514, 
Spectral data of 4j: 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 
9.2 Hz, 1H), 7.10 – 7.03 (m, 1H), 6.89 – 6.84 (m, 1H), 6.57 (dd, J = 7.6, 3.8 Hz, 1H), 
5.96 (d, J = 9.0 Hz, 1H), 3.59 (dd, J = 15.0, 1.4 Hz, 1H), 3.40 (dd, J = 15.0, 9.6 Hz, 1H), 
2.47 (s, 3H), 2.05 – 1.97 (m, 1H), 1.95 – 1.80 (m, 1H), 1.40 – 1.23 (m, 5H), 0.95 – 
0.90 (m, 3H), 0.78 – 0.68 (m, 2H), 0.57 – 0.51 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
161.1, 144.6, 137.2, 135.9, 131.2, 129.6 (2C), 128.5, 128.4 (2C), 124.8, 123.5, 121.1, 
110.7, 78.6, 60.9, 30.2, 27.1, 23.0, 21.6, 15.0, 13.9, 6.1, 5.6; IR (neat) 2959, 2931, 2872, 1724, 1635, 1598, 
1460, 1386, 1364, 1320, 1302, 1290, 1262, 1231, 1201, 1140, 1083, 1019, 984, 950, 923, 850, 813, 747, 
725, 661, 632, 601, 581, 541, 514, 463 cm-1. 
Compound 3k. The outcome of the reaction was found to be strongly time-dependent. Upon quenching of 
the cold reaction mixture after 10 min, E,Z-3k was obtained as the major product (95%, 
Z/E = 76:4); on prolonged stirring at 30°C, the Z/E decreases significantly (49:51 after 
90 min) and variable amounts of the cyclized product 4k were also detected. 
Spectral data of compound E,Z-3k: yellow solid; m.p. = 144 – 146 °C. 1H NMR (400 MHz, 
CDCl3) δ 8.12 (d, J = 15.4 Hz, 1H), 7.14 – 6.98 (m, 6H), 6.80 (dd, J = 7.9, 2.0 Hz, 1H), 6.75 
– 6.70 (m, 2H), 5.54 (d, J = 15.4 Hz, 1H), 4.98 (s, 1H), 3.73 (s, 3H), 2.47 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
168.0, 152.7, 148.5, 142.4, 142.1, 131.6, 130.2, 129.0, 127.7 (2C), 127.5 (2C), 127.3, 124.8, 120.9, 120.4, 
115.4, 51.6, 21.3; IR (neat) 3340, 3062, 3039, 2952, 2919, 2849, 1735, 1689, 1613, 1603, 1578, 1487, 
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1459, 1434, 1379, 1330, 1308, 1296, 1255, 1236, 1193, 1175, 1132, 1078, 1038, 1027, 1016, 991, 974, 
943, 919, 867, 841, 792, 763, 752, 734, 700, 643, 594, 553, 535, 520, 507, 494, 463, 423 cm-1; MS (EI) m/z 
(%): 31 (7), 51 (6), 63 (5), 77 (22), 91 (18), 103 (39), 115 (26), 131 (14), 165 (14), 178 (18), 191 (19), 202 
(26), 221 (100), 234 (47), 247 (25), 262 (14), 279 (30), 294 (58); HRMS (APPIpos): calcd for C19H18O3: 
294.12505; found: 294.12524. 
Spectral data of compound E,E-3k: 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 15.6 Hz, 1H), 7.46 – 7.36 (m, 
3H), 7.32 – 7.26 (m, 3H), 7.06 (dd, J = 8.0, 1.8 Hz, 1H), 7.00 (app. t, J = 6.3 Hz, 2H), 5.41 
(d, J = 15.5 Hz, 1H), 4.93 (s, 1H), 3.62 (s, 3H), 2.01 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
167.7, 152.5, 150.5, 143.6, 141.0, 130.5, 130.2, 129.5, 128.5 (2C), 128.5 (2C), 128.2, 
124.2, 121.0, 120.1, 115.7, 51.4, 23.7; IR (neat) 3397, 3059, 3029, 2995, 2950, 2909, 
2846, 1686, 1606, 1588, 1487, 1445, 1371, 1309, 1287, 1265, 1194, 1170, 1126, 1090, 
1065, 1046, 1026, 1001, 985, 911, 866, 840, 797, 754, 731, 701, 647, 616, 599, 554, 542, 513, 484, 461, 
418 cm-1; MS (EI) m/z (%): 31 (10), 51 (9), 77 (30), 107 (46), 142 (31), 157 (13), 165 (21), 178 (23), 202 
(46), 221 (100), 234 (100), 247 (56), 262 (32), 279 (31), 294 (94); HRMS (ESIpos): calcd for C19H18O3Na : 
317.11481; found : 317.11464. 
Spectral data of compound 4k: yellow oil, 28% yield (E/Z > 99:1, NMR); 1H NMR (400 MHz, CDCl3) δ 7.43 
(app. t, J = 7.2 Hz, 2H), 7.37 (app. d, J = 7.3 Hz, 1H), 7.25 (d, J = 7.0 Hz, 2H), 7.03 (app. t, J 
= 7.3 Hz, 1H), 6.81 (d, J = 8.0 Hz, 1H), 6.52 (td, J = 7.8, 0.9 Hz, 1H), 6.20 (d, J = 7.8 Hz, 1H), 
5.86 (dd, J = 8.9 Hz, 1H), 3.77 (s, 3H), 2.87 (dd, J = 16.0, 2.4 Hz, 1H), 2.71 (dd, J = 16.0, 9.8 
Hz, 1H), 2.12 (d, J = 1.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.0, 161.9, 142.6, 133.8, 
129.5, 129.2, 129.0 (2C), 127.7 (2C), 127.4, 124.7, 123.6, 120.3, 110.6, 81.1, 52.0, 39.8, 
23.3; IR (neat) 3076, 3053, 3021, 2951, 2852, 1737, 1602, 1586, 1491, 1461, 1437, 1405, 
1369, 1334, 1273, 1245, 1222, 1164, 1120, 1107, 1072, 1024, 1011, 987, 888, 848, 803, 748, 702, 656, 
610, 590, 538, 507, 444 cm-1; MS (EI) m/z (%): 77 (5), 91 (5), 103 (17), 115 (12), 131 (4), 165 (8), 178 (12), 
191 (12), 202 (12), 221 (100), 234 (19), 262 (3), 279 (31), 294 (57); HRMS (ESIpos): calcd for C19H18O3Na: 
317.11481; found: 317.11503. 
Compound 3l. Isolated as a mixture with unreacted starting material (68% brsm, Z/E = 90:10 NMR). An 
analytically pure sample of 3l was obtained by preparative HPLC (150 mm YMC-Actus 
Triart C18, 5µm, 20 mm i.D., CH3CN/H2O = 70:30, 10 mL/min). 
1H NMR (400 MHz, 
CDCl3) δ 7.93 (d, J = 15.4 Hz, 1H), 7.67 (dd, J = 8.2, 1.1 Hz, 1H), 7.35 (td, J = 8.1, 1.6 Hz, 
1H), 7.14 (td, J = 7.5, 1.1 Hz, 1H), 6.98 (dd, J = 7.6, 1.6 Hz, 1H), 6.17 (s, 1H), 5.16 (d, J = 
15.4 Hz, 1H), 3.70 (s, 3H), 2.93 (s, 3H), 2.15 (s, 3H), 1.88 (t, J = 7.9 Hz, 2H), 1.45 – 1.23 (m, 2H), 1.13 (h, J = 
7.3 Hz, 2H), 0.75 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 167.4, 152.4, 141.8, 134.7, 131.1, 129.2, 
128.5, 127.8, 124.4, 119.3, 117.6, 51.6, 39.4, 36.8, 29.9, 22.6, 18.4, 13.7; IR (neat) 3276, 2955, 2931, 2871, 
2861, 1713, 1614, 1579, 1492, 1451, 1434, 1394, 1335, 1308, 1280, 1192, 1158, 1132, 1112, 1071, 1042, 
971, 913, 864, 817, 756 cm-1; MS (EI) m/z (%): 130 (7), 156 (11), 170 (11), 184 (37), 212 (10), 216 (24), 271 (100), 351 
(2); HRMS (ESIpos): calcd for C18H26NO4S [M+H]
+ 352.15779; found: 352.15771. 
Compound 6. Colorless oil (81% yield, Z/E = 95:5, NMR). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 15.7 Hz, 
1H), 5.87 (d, J = 15.7 Hz, 1H), 4.47 (t, J = 4.9 Hz, 1H), 4.07 (dd, J = 10.7, 5.0 Hz, 2H), 3.75 (s, 
3H), 3.69 (td, J = 12.4, 2.6 Hz, 2H), 3.63 (t, J = 6.9 Hz, 2H), 2.59 (t, J = 7.0 Hz, 2H), 2.47 (t, J = 
7.3 Hz, 2H), 2.10 – 1.99 (m, 1H), 1.93 (s, 3H), 1.75 (td, J = 7.3, 4.9 Hz, 3H), 1.30 (dt, J = 13.5, 
1.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 168.3, 148.2, 142.4, 127.2, 115.5, 101.4, 66.8 (2C), 
61.2, 51.5, 33.5, 31.5, 29.0, 25.6, 20.7; IR (neat) 3449, 2954, 2931, 2852, 1702, 1612, 1461, 
1434, 1403, 1378, 1303, 1285, 1262, 1193, 1178, 1133, 1101, 1077, 1038, 1000, 981, 948, 926, 883, 854, 
809, 752, 666, 638, 583, 550, 469, 443 cm-1; MS (ESIpos) m/z = 307 ([M+Na]), 591 ([2M+Na]); HRMS 
(ESIpos): calcd for C15H24O5Na: 307.15159; found: 307.15130. 
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Compound 8. Colorless oil (70% yield Z/E = 99:1, NMR); 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 15.6 Hz, 
1H), 5.85 (d, J = 15.6 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.75 (s, 6H), 3.37 (t, J = 7.4 
Hz, 1H), 2.87 – 2.82 (m, 1H), 2.28 – 2.24 (m, 2H), 1.94 – 1.88 (m, 2H), 1.76 (s, 
3H), 1.76 – 1.67 (m, 3H), 1.45 (app. d, J = 7.8 Hz, 2H), 1.36 – 1.23 (m, 4H), 1.30 
(t, J = 7.1 Hz, 3H), 1.19 – 1.12 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 169.6, 168.2, 
151.8, 141.2 (2C), 128.2, 115.5, 60.2, 52.5 (2C), 51.4, 41.2, 31.0 (2C), 27.4, 26.5, 
26.2 (2C), 26.0, 15.3, 14.3; IR (neat) 2929, 2853, 1734, 1706, 1610, 1436, 1365, 1290, 1254, 1223, 1185, 
1150, 1094, 1036, 977, 931, 887, 861, 820, 793, 763, 741, 712, 697, 629, 590, 556, 512, 476, 461, 440 cm-1; 
MS (EI) m/z (%): 55 (19), 67 (22), 91 (30), 105 (34), 145 (40), 174 (87), 192 (40), 202 (25), 248 (83), 269 
(19), 297 (100), 306 (11), 334 (24), 380 (15); HRMS (ESIpos): calcd for C21H32O6Na: 403.20911; found: 
403.20923. 
Compound 9. Colorless oil (63% yield, Z/E > 98:2, NMR); 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 15.7 Hz, 
1H), 5.84 (d, J = 15.6 Hz, 1H), 4.41 (t, J = 5.2 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 
4.10 – 4.06 (m, 2H), 3.75 (s, 6H), 3.75 – 3.64 (m, 3H), 3.37 (t, J = 7.3 Hz, 1H), 
2.41 (t, J = 7.4 Hz, 2H), 2.30 – 2.26 (m, 2H), 2.05 (qt, J = 12.6, 5.0 Hz, 1H), 1.96 – 
1.90 (m, 2H), 1.86 (s, 3H), 1.72 – 1.67 (m, 2H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 169.6 (2C), 167.9, 146.1, 141.6, 130.0, 115.9, 101.1, 66.8 
(2C), 60.1, 52.6 (2C), 51.4, 33.7, 28.8, 27.4, 26.1, 25.7, 20.0, 14.3; IR (neat) 2956, 2851, 1733, 1706, 1614, 
1461, 1435, 1402, 1378, 1366, 1344, 1289, 1256, 1228, 1182, 1146, 1100, 1077, 1041, 1002, 929, 884, 
855, 797, 739, 638, 594, 490, 459 cm-1; MS (EI) m/z (%): 59 (11), 79 (5), 87 (47), 100 (23), 113 (100), 131 
(27), 145 (12), 158 (46), 178 (10), 204 (23), 226 (7), 259 (5), 290 (22), 325 (10), 367 (5), 412 (8); HRMS 
(ESIpos): calcd for C21H32O8Na: 435.19894; found: 435.19885. 
Compounds 12 and 14. Isolated as an inseparable mixture in the form of a colorless oil (combined yield 
53%, 12:14 = 3.8:1, NMR). Characteristic data: 1H NMR (500 MHz, 
CDCl3) δ 6.78 (dd, J = 17.3, 11.1 Hz, 1H), 5.15 (d, J = 17.7 Hz, 1H), 
4.98 (d, J = 11.1 Hz, 1H), 3.74 (s, 6H), 3.38 (t, J = 7.4 Hz, 1H), 2.70 – 
2.67 (m, 1H), 2.27 – 2.24 (m, 2H), 1.96 – 1.92 (m, 2H), 1.76 – 1.69 
(m, 3H), 1.66 (s, 3H), 1.47 – 1.45 (m, 2H), 1.35 – 1.25 (m, 4H), 1.18 – 
1.13 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 169.9 (2C), 141.5, 133.5, 
129.1, 111.3, 52.4 (2C), 51.6, 40.7, 31.0 (2C), 27.7, 26.6 (2C), 26.2, 26.0, 14.4; IR (neat) 2928, 2852, 1735, 
1620, 1436, 1345, 1280, 1257, 1236, 1222, 1200, 1153, 1088, 1056, 1041, 1020, 988, 890, 843, 803 cm-1; 
MS (EI) m/z (%): 31 (7), 41 (21), 55 (31), 67 (27), 79 (50), 91 (42), 105 (51), 120 (34), 133 (67), 147 (100), 
161 (49), 176 (81), 201 (6), 248 (6), 308 (12); HRMS (ESIpos): calcd for C18H28O4Na: 331.18798; found: 
331.18781. 
Compound 17. Colorless oil (67% yield); 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 7.5 
Hz, 1H), 7.26 (app. t, J = 7.9 Hz, 1H), 7.17 (app. t, J = 7.3 Hz, 1H), 4.15 – 4.07 (m, 2H), 
3.83 – 3.80 (m, 1H), 3.80 (s, 1H), 3.67 (s, 3H), 2.63 (ddd, J = 13.4, 10.7, 5.1 Hz, 1H), 
2.48 (dd, J = 15.8, 3.9 Hz, 1H), 2.21 (dd, J = 15.8, 11.5 Hz, 1H), 2.24 – 2.15 (m, 1H), 1.95 
(s, 3H), 1.62 – 1.38 (m, 4H), 1.23 (t, J = 7.1 Hz, 3H), 0.97 (t, J = 7.0 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 173.1, 172.3, 141.3, 140.2, 136.2, 133.6, 128.0, 126.7, 126.4, 
124.6, 60.5, 53.4, 52.2, 43.1, 38.8, 34.7, 30.2, 22.9, 21.3, 14.2, 14.1; IR (neat) 2955, 
2929, 2860, 1732, 1653, 1597, 1459, 1434, 1370, 1338, 1295, 1247, 1199, 1157, 1094, 1064, 1026, 944, 
918, 887, 861, 755, 726 cm-1; MS (ESIpos) m/z: 345 ([M+H]), 362 ([M+NH4]), 367 ([M+Na]), 383 ([M+K]), 




Compounds 20 and 21. The reaction was carried out with 1 equivalent of Fe(acac)3, 2 equivalents of 
MeMgBr at –30 °C (50 min) and then at –15 °C (16 h); the crude product (quant.) was a mixture of 20 and 
21 (69:31, NMR). Pure samples were obtained by preparative HPLC (150 mm YMC-Actus Triart C18, 5µm, 
20 mm i.D., CH3CN/H2O = 90:10, 15 mL/min). During isolation, one has to be careful as both products are 
volatile in vacuum. Spectral data of compound 20: 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 7.5 
Hz, 1H), 7.24 (d, J = 6.6 Hz, 1H), 7.17 (td, J = 7.0, 1.0 Hz, 1H), 7.13 (td, J = 7.3, 1.2 Hz, 1H), 3.18 
– 3.09 (m, 2H), 2.60 (ddd, J = 13.3, 10.6, 5.4 Hz, 1H), 2.44 (d, J = 14.8 Hz, 1H), 2.18 (ddd, J = 
13.3, 10.3, 5.5 Hz, 1H), 1.89 (s, 3H), 1.63 – 1.38 (m, 4H), 1.01 – 0.96 (m, 6H); 13C NMR (100 
MHz, CDCl3) δ 145.5, 140.8, 140.2, 130.9, 126.2, 126.1, 125.6, 124.5, 38.8, 37.4, 34.6, 30.4, 23.0, 20.9 (2C), 
14.2; IR (neat) 3067, 3019, 2956, 2926, 2860, 1458, 1376, 766, 723 cm-1; MS (EI) m/z (%): 115 (17), 128 
(26), 129 (34), 130 (12), 143 (100), 157 (21), 158 (10), 171 (70), 214 (65); HRMS (APPIpos): calcd for 
C16H22: 214.17132; found: 214.17160. 
Spectral data of compound 21: 1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.4 Hz, 1H), 7.22 (d, J = 7.2 Hz, 1H), 
7.16 (t, J = 7.2 Hz, 1H), 7.11 (td, J = 7.3, 1.2 Hz, 1H), 3.05 (dd, J = 15.8, 7.5 Hz, 1H), 2.94 (td, J 
= 8.3, 4.6 Hz, 1H), 2.63 (ddd, J = 13.3, 10.8, 5.2 Hz, 1H), 2.59 (d, J = 15.8 Hz, 1H), 2.15 (ddd, J 
= 13.3, 10.4, 5.4 Hz, 1H), 1.89 (s, 3H), 1.64 – 1.31 (m, 5H), 1.30 – 1.20 (m, 1H), 0.98 (t, J = 
7.1 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 145.8, 140.9, 139.8, 131.3, 
126.1, 125.9, 125.3, 124.3, 44.5, 35.8, 34.7, 30.6, 28.0, 23.0, 21.3, 14.2, 11.8; IR (neat) 3065, 3018, 2957, 
2927, 2871, 2858, 1649, 1599, 1459, 1377, 768, 734 cm-1; MS (EI) m/z (%): 41 (10), 43 (12), 55 (12), 115 
(20), 128 (28), 129 (35), 143 (100), 157 (14), 171 (11), 185 (21), 228 (26); HRMS (APPIpos): calcd for C17H24: 
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